BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 21571956)

  • 21. Tissue microarray based immunohistochemical study of TLE1 in synovial sarcoma and its histologic mimics.
    Sivakoti S; Uppin SG; Uppin MS; Tara RP; Prayaga AK; Challa S
    Indian J Pathol Microbiol; 2021; 64(2):310-315. PubMed ID: 33851625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas.
    Cajaiba MM; Jianhua Luo ; Goodman MA; Fuhrer KA; Rao UN
    Int J Surg Pathol; 2010 Oct; 18(5):319-23. PubMed ID: 20484142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
    Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
    Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.
    Lyons SA; O'Neal J; Sontheimer H
    Glia; 2002 Aug; 39(2):162-73. PubMed ID: 12112367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Utility of TLE1 (Transducer-Like Enhancer of Split 1) in Distinguishing Synovial Sarcoma from Mimicking Tumors.
    Qureshi MB; Tariq MU; Abdul-Ghafar J; Chundriger Q; Ud Din N
    Int J Gen Med; 2021; 14():9173-9179. PubMed ID: 34880656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of TLE1 in synovial sarcoma.
    Seo SW; Lee H; Lee HI; Kim HS
    J Orthop Res; 2011 Jul; 29(7):1131-6. PubMed ID: 21319215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transducer-like enhancer of split 1 (TLE1) expression as a diagnostic immunohistochemical marker for synovial sarcoma and its association with morphological features.
    Bakrin IH; Hussain FA; Tuan Sharif SE
    Malays J Pathol; 2016 Aug; 38(2):117-22. PubMed ID: 27568668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma. Is there any role in disease process?
    Kara IO; Gonlusen G; Sahin B; Ergin M; Erdogan S
    Saudi Med J; 2005 Aug; 26(8):1190-6. PubMed ID: 16127511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types.
    Thorner P; Squire J; Chilton-MacNeil S; Marrano P; Bayani J; Malkin D; Greenberg M; Lorenzana A; Zielenska M
    Am J Pathol; 1996 Apr; 148(4):1125-38. PubMed ID: 8644855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histology, immunohistochemistry, and electron microscopy of small round cell tumors of bone.
    Llombart-Bosch A; Contesso G; Peydro-Olaya A
    Semin Diagn Pathol; 1996 Aug; 13(3):153-70. PubMed ID: 8875707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of TLE1 expression and fluorescence in-situ hybridization in diagnosing poorly differentiated synovial sarcoma].
    Mao RJ; Li QM; Fang HQ; Han FL; Huang XF; Wu YX; Zeng M
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):403-5. PubMed ID: 21914350
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of SYT and EWS gene rearrangements by dual-color break-apart CISH in liquid-based cytology samples of synovial sarcoma and Ewing sarcoma/primitive neuroectodermal tumor.
    Kumagai A; Motoi T; Tsuji K; Imamura T; Fukusato T
    Am J Clin Pathol; 2010 Aug; 134(2):323-31. PubMed ID: 20660338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soft tissue sarcomas of childhood: the differential diagnostic dilemma of the small blue cell.
    Dehner LP
    Natl Cancer Inst Monogr; 1981 Apr; (56):43-59. PubMed ID: 6272117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytologic features of synovial sarcoma with emphasis on the monophasic fibrous variant: a morphologic and immunocytochemical analysis of bcl-2 protein expression.
    Viguer JM; Jiménez-Heffernan JA; Vicandi B; López-Ferrer P; Gamallo C
    Cancer; 1998 Feb; 84(1):50-6. PubMed ID: 9500652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study.
    O'Sullivan MJ; Kyriakos M; Zhu X; Wick MR; Swanson PE; Dehner LP; Humphrey PA; Pfeifer JD
    Mod Pathol; 2000 Nov; 13(11):1253-63. PubMed ID: 11106084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
    Ito J; Asano N; Kawai A; Yoshida A
    Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical and ultrastructural investigation of neural differentiation in Ewing sarcoma/PNET of bone and soft tissues.
    Franchi A; Pasquinelli G; Cenacchi G; Della Rocca C; Gambini C; Bisceglia M; Martinelli GN; Santucci M
    Ultrastruct Pathol; 2001; 25(3):219-25. PubMed ID: 11465478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunostaining for SYT protein discriminates synovial sarcoma from other soft tissue tumors: analysis of 146 cases.
    He R; Patel RM; Alkan S; Hammadeh R; Weiss SW; Goldblum JR; Venkataraman G; Baila H
    Mod Pathol; 2007 May; 20(5):522-8. PubMed ID: 17334346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue.
    Yamaguchi U; Hasegawa T; Morimoto Y; Tateishi U; Endo M; Nakatani F; Kawai A; Chuman H; Beppu Y; Endo M; Kurotaki H; Furuta K
    J Clin Pathol; 2005 Oct; 58(10):1051-6. PubMed ID: 16189150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.